Despite impressive growth and acceptance by the mainstream financial world, the psychedelic medicine industry is still in its infancy. The first companies went public in the spring of 2020, making the psychedelics industry a newcomer to the biotech scene. Despite this, the sector continues to make great strides, securing institutional investments and listings on major US stock exchanges like NASDAQ and NYSE.

A missing piece of the industry growth puzzle was industry events and face-to-face networking. With Covid-19 shutting down the world just as psychedelic companies were launching, the industry has missed this crucial part of its evolution. However, with the restrictions starting to loosen, the industry now has a chance for very important networking, education and dynamic interactions that can only happen when people can meet face to face. While other smaller industry events have been taking place in recent years, an upcoming event seeks to establish itself as the unmissable event for psychedelic medicine.

Wonderland by Microdose Psychedelic Insights

Since its creation less than 2 years ago, Microdose has quickly established itself commercially in psychedelic medicine. The media company has been hosting virtual events for over a year, with dozens of virtual conferences that have brought together industry leaders, CEOs, scientists and investors. His Psychedelic Capital and Molecular Masterclass series has been very successful in helping the industry come together and create a virtual network.

Now Microdose takes another step forward with Wonderland. Wonderland will take place November 8-9, 2021 at the Adrienne Arsht Center for the Performing Arts in downtown Miami. The event will be the industry’s largest ever event, with over 2,000 attendees and an impressive roster of industry researchers, investors, journalists and CEOs.

As described in the company press release: Wonderland: Miami will provide the industry with a unique in-person convergence of business, science, music and emerging technologies. The event is a thought leadership platform and an opportunity to connect with influential leaders in science, policy and business. It will also serve as a launching pad for innovative content related to the psychedelic medicine space, with musical showcases and documentary screenings, providing compelling entertainment and collaboration opportunities for attendees.

Microdose has announced an impressive roster of speakers, here are some highlights:

Mike Tyson, Wesana Health

Mike Tyson, an investor in Wesana and a business advisor, suffered a head injury. The former heavyweight champion says psychedelics would have helped him with his sanity during his career.

Lamar Odom, mental health advocate

Lamar Odom, two-time NBA champion, Olympic gold medalist, NYT bestselling author and former drug addict, is now entering his second half of life as a savvy businessman, mental health advocate and mentor .

Dr Robin Carhart-Harris, PhD, Professor of Neurology and Psychiatry

Robin Carhart-Harris has published over 115 scientific papers. He founded the Center for Psychedelic Research at Imperial College London in April 2019. In 2021, he was on TIME magazine’s “100 Next” list, a list of 100 rising stars shaping the future.

Dr Matthew Johnson, Johns Hopkins University School of Medicine

Matthew W. Johnson, Ph.D., is the Susan Hill Ward Professor of Psychedelics and Consciousness Research at Johns Hopkins University School of Medicine. He is one of the world’s most published experts on psychedelics, publishing over 150 scientific papers. He has been interviewed by Anderson Cooper on 60 Minutes, The New York Times, The Washington Post, The Wall Street Journal, BBC, CNN, Fox Business News, NPR and in Michael Pollan’s book How to Change Your Mind.

Rick Doblin, MAPS Executive Director

Rick Doblin, Ph.D., is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), an organization that has led the charge for the advancement of psychedelics for decades.

In addition to top speakers, the event will also feature a range of programs covering a variety of topics surrounding the psychedelics industry and beyond. Here are some examples :

  • The road to federal acceptance
  • Next Generation Psychedelics
  • Microdosing: fact or fiction?
  • Patent wars
  • Finance and psychedelics

By Richard Skaife, president of Microdose and founding partner of The Conscious Fund:

“We launched Microdose at the start of what was to become a global lockdown for most of the world; quickly becoming a category leader in virtual events and industry information for the psychedelic medicine industry. Moving forward 15 months as the world begins to return to an open economy, we’re excited to bring our next event format to life: Wonderland, from Microdose.

Wonderland is all about real life events. High quality programming in some of the world’s most exciting places and breathtaking locations. Wonderland in Miami will be the first time the industry meets in person for many. We can’t wait to welcome you to Miami to see what we’ve created.

Wonderland will take place from November 8 to 9, 2021. For more information on the event, see the wonderland site.


Publication displays:
150


Source link